Evidence map›Paper›PMID 29422895›Full record

ReviewFrontiers in immunology2018

Tunneling Nanotubes: Intimate Communication between Myeloid Cells.

Maeva Dupont, Shanti Souriant, Geanncarlo Lugo-Villarino, Isabelle Maridonneau-Parini, Christel Vérollet

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed.

  1. Myosin II-independent contraction of actin filaments in membrane nanotubes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maeva DupontInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Toulouse III Paul Sabatier, Toulouse, France.
Shanti SouriantInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Toulouse III Paul Sabatier, Toulouse, France.
Geanncarlo Lugo-VillarinoInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Toulouse III Paul Sabatier, Toulouse, France.
Isabelle Maridonneau-PariniInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Toulouse III Paul Sabatier, Toulouse, France.
Christel VérolletInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Toulouse III Paul Sabatier, Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tunneling nanotubes (TNT) are dynamic connections between cells, which represent a novel route for cell-to-cell communication. A growing body of evidence points TNT towards a role for intercellular exchanges of signals, molecules, organelles, and pathogens, involving them in a diverse array of functions. TNT form among several cell types, including neuronal cells, epithelial cells, and almost all immune cells. In myeloid cells (e.g., macrophages, dendritic cells, and osteoclasts), intercellular communication

Indexed as

NanotubesAnimalsCell CommunicationHIV-1HIV InfectionsHumansImmunity, InnateImmunologic SurveillanceMiceMyeloid CellsRatsHIV-1innate immunitymyeloid cellspathogenstunneling nanotubes

Identifiers

PMID29422895
PMCPMC5788888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.